Search Within

Peter Justin Wan

Formats
  1. Meeting Abstract (7)
  2. Journal Article (4)
Groups
  1. Department of Medicine (11)
  2. Advanced Practice Providers (9)
  3. Gastrointestinal Oncology Service (9)
  4. Nursing (9)
  5. Solid Tumor Oncology Division (9)
  6. Center for Pancreatic Cancer Research (5)

More Groups

People
  1. Ghassan Abou-Alfa (7)
  2. Ellen Hollywood (5)
  3. James Harding (5)
  4. Anjali Desai (4)
  5. Dana Kramer (4)
  6. Jessica Goldberg (4)

More People

Years
  1. 2019 (1)
  2. 2018 (3)
  3. 2017 (5)
  4. 2015 (1)
  5. 2014 (1)
Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Chemotherapy and Pharmacology (2)
  3. Leukemia Research (2)
  4. Annals of Oncology (1)
  5. Journal of Pain and Symptom Management (1)
Publishers
  1. American Society of Clinical Oncology (5)
  2. Elsevier Ltd (2)
  3. Springer (2)
  4. Elsevier Inc. (1)
  5. Oxford University Press (1)

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Giving voice to patient values throughout cancer: A novel nurse-led intervention
    Journal Article

    Epstein, A. S.; Desai, A. V.; Bernal, C.; Romano, D.; Wan, P. J.; Okpako, M.; Anderson, K.; Chow, K.; Kramer, D.; Calderon, C.; more...
    Journal of Pain and Symptom Management (2019)

    Fulltext@MSK | Save
  • ADI-PEG 20 and FOLFOX6: A phase 1 study in pts (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Do, R. K. G.; Hollywood, E.; Uhlitskykh, K.; Valentino, E.; Wan, P. J.; Hamilton, C. R.; Frick, J.; Feng, X.; Johnston, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies
    Journal Article

    Harding, J. J.; Do, R. K.; El Dika, I.; Hollywood, E.; Uhlitskykh, K.; Valentino, E.; Wan, P.; Hamilton, C.; Feng, X.; Johnston, A.; more...
    Cancer Chemotherapy and Pharmacology (2018)

    Fulltext@MSK | Save
  • Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Qin, S.; Ryoo, B. Y.; Lu, S. N.; Yen, C. J.; Feng, Y. H.; Lim, H. Y.; Izzo, F.; Colombo, M.; Sarker, D.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • A phase I study of mFOLFOX6 and ADI-PEG-20 in patients (pts) with advanced hepatocellular carcinoma (HCC) and other gastrointestinal (GI) malignancies
    Meeting Abstract

    Harding, J. J.; Lowery, M. A.; Uhlitskykh, K.; Wan, P. J.; Hamilton, C. R.; Barba, A.; Liu, K. C. W.; Johnston, A.; Bomalaski, J. S.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Palliative care from cancer diagnosis for all: Memorial Sloan Kettering's "One-Two-Three" program
    Meeting Abstract

    Epstein, A. S.; Klimek, V. M.; Chow, K.; Desai, A. V.; Wan, P. J.; Anderson, K.; Ranghan, C.; Okpako, M.; Rawlins-Duell, R.; Kramer, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Symptom burden of patients with newly diagnosed myelodysplastic syndromes (MDS) receiving outpatient cancer care
    Meeting Abstract

    Desai, A. V.; Goldberg, J. I.; Anderson, K.; Ranaghan, C.; O'shea, D.; Chow, K.; Kramer, D.; Rawlins, R.; Wan, P. J.; Klimek, V. M.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Impact of early integration of palliative care on health care proxy (HCP) documentation by patients with myelodysplastic syndromes (MDS)
    Meeting Abstract

    Desai, A. V.; Chow, K.; Wan, P. J.; O'shea, D.; Ranaghan, C.; Anderson, K.; Kramer, D.; Goldberg, J. I.; Rawlins, R.; Koczela, E.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
    Journal Article

    Abou-Alfa, G. K.; Yen, C. J.; Hsu, C. H.; O'Donoghue, J.; Beylergil, V.; Ruan, S.; Pandit-Taskar, N.; Gansukh, B.; Lyashchenko, S. K.; Ma, J.; more...
    Cancer Chemotherapy and Pharmacology (2017)

    Fulltext@MSK | Save
  • First stage results of a phase II trial of sorafenib plus doxorubicin (SD) in patients (pts) with advanced hepatocellular carcinoma (HCC) who progressed (POD) on sorafenib (S)
    Meeting Abstract

    Abou-Alfa, G. K.; Capanu, M.; Do, R. K. G.; Hollywood, E.; Ly, M.; Chou, J. F.; Lee, J. K.; Connell, L. C.; Wan, P. J.; Bradley, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save